Lisa Kasiewicz

Lisa Kasiewicz is an associate principal scientist, and formulation at Verve Therapeutics with expertise in RNAi, gene therapy, and lipid nanoparticle nucleic acid delivery technology. She received her Ph.D. in chemical engineering from Carnegie Mellon University, where her research into diabetic wound healing transitioned into how nanoparticle design can enhance delivery to or avoid interaction with the immune system. Dr. Kasiewicz received her B.S. in chemical engineering from Columbia University.